Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin intestinal mucosal biopsy mechanism study in type 2 diabetes
jRCT1051210063Recruiting
- Sponsor
- Manpei Suzuki Diabetes Foundation
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Manpei Suzuki Diabetes Foundation. Primary endpoint: Gene expression level of GLUT2. Started Aug 2021; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1051210063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051210063.